UB Paderborn / Katalog / Suche / in CDI

Effectiveness of BNT162b2 COVID-19 primary series vaccination in children aged 5-17 years in the United States: a cohort study

BMC pediatrics, 2024-04, Vol.24 (1), p.276-276

2024

Link zum Volltext

Verfügbarkeit prüfen

Influenza vaccination coverage estimates in the fee-for service Medicare beneficiary population 2006 - 2016: Using population-based administrative data to support a geographic based near real-time tool

Human vaccines & immunotherapeutics, 2018-08, Vol.14 (8), p.1848-1852

2018

Link zum Volltext

Verfügbarkeit prüfen

Patterns of seasonal influenza activity in U.S. core-based statistical areas, described using prescriptions of oseltamivir in Medicare claims data

Epidemics, 2019-03, Vol.26, p.23-31

2019

Link zum Volltext

Verfügbarkeit prüfen

Relative Effectiveness of Cell-Cultured and Egg-Based Influenza Vaccines Among Elderly Persons in the United States, 2017–2018

The Journal of infectious diseases, 2019-09, Vol.220 (8), p.1255-1264

2019

Link zum Volltext

Verfügbarkeit prüfen

Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018–2019

The Journal of infectious diseases, 2020-06, Vol.222 (2), p.278-287

2020

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation

Circulation (New York, N.Y.), 2015-01, Vol.131 (2), p.157-164

2015

Link zum Volltext

Verfügbarkeit prüfen

Comparative Effectiveness of Influenza Vaccines Among US Medicare Beneficiaries Ages 65 Years and Older During the 2019-2020 Season

Clinical infectious diseases, 2021-12, Vol.73 (11), p.e4251-e4259

2021

Link zum Volltext

Verfügbarkeit prüfen

Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation

JAMA internal medicine, 2016-11, Vol.176 (11), p.1662

2016

Link zum Volltext

Verfügbarkeit prüfen

Natural History of Coronavirus Disease 2019: Risk Factors for Hospitalizations and Deaths Among >26 Million US Medicare Beneficiaries

The Journal of infectious diseases, 2021-03, Vol.223 (6), p.945-956

2021

Link zum Volltext

Verfügbarkeit prüfen

Recombinant Zoster Vaccine (Shingrix): Real-World Effectiveness in the First 2 Years Post-Licensure

Clinical infectious diseases, 2021-09, Vol.73 (6), p.941-948

2021

Link zum Volltext

Verfügbarkeit prüfen

The Reply

The American journal of medicine, 2019-10, Vol.132 (10), p.e754-e755

2019

Link zum Volltext

Verfügbarkeit prüfen

Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation

The American journal of medicine, 2019-05, Vol.132 (5), p.596-604.e11

2019

Link zum Volltext

Verfügbarkeit prüfen

Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products

JAMA : the journal of the American Medical Association, 2015-11, Vol.314 (19), p.2062

2015

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older

Clinical infectious diseases, 2017-03, Vol.64 (6), p.785-793

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012–2013 and 2013–2014

The Journal of infectious diseases, 2017-02, Vol.215 (4), p.510-517

2017

Link zum Volltext

Verfügbarkeit prüfen

Severe Hypoglycemia Risk With Long-Acting Insulin Analogs vs Neutral Protamine Hagedorn Insulin

JAMA internal medicine, 2021-05, Vol.181 (5), p.598

2021

Link zum Volltext

Verfügbarkeit prüfen

Uptake and Competition Among Biosimilar Biological Products in the US Medicare Fee-for-Service Population

Journal of general internal medicine : JGIM, 2022-12, Vol.37 (16), p.4292-4294

2022

Link zum Volltext

Verfügbarkeit prüfen

Risk of Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in Medicare Beneficiaries

JAMA internal medicine, 2021-12, Vol.181 (12), p.1623

2021

Link zum Volltext

Verfügbarkeit prüfen

Mortality Among Parkinson’s Disease Patients Treated With Pimavanserin or Atypical Antipsychotics: An Observational Study in Medicare Beneficiaries

The American journal of psychiatry, 2022-08, Vol.179 (8), p.553-561

2022

Link zum Volltext

Verfügbarkeit prüfen

Association of Pneumococcal Conjugate Vaccine Use With Hospitalized Pneumonia in Medicare Beneficiaries 65 Years or Older With and Without Medical Conditions, 2014 to 2017

JAMA internal medicine, 2023-01, Vol.183 (1), p.40

2023

Link zum Volltext

Verfügbarkeit prüfen

Effect of Age on Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries Aged ≥65 Years

The Journal of infectious diseases, 2019-11, Vol.220 (9), p.1511-1520

2019

Link zum Volltext

Verfügbarkeit prüfen

Uptake of the Biologic Filgrastim and Its Biosimilar Product Among the Medicare Population

JAMA : the journal of the American Medical Association, 2018-09, Vol.320 (9), p.929

2018

Link zum Volltext

Verfügbarkeit prüfen

Uptake and Usage Patterns of Biosimilar Infliximab in the Medicare Population

Journal of general internal medicine : JGIM, 2021-07, Vol.36 (7), p.2170-2173

2021

Link zum Volltext

Verfügbarkeit prüfen

Severe Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent Patients

JAMA : the journal of the American Medical Association, 2024-02, Vol.331 (6), p.491

2024

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Effectiveness of BNT162b2 COVID-19 primary series vaccination in children aged 5-17 years in the United States: a cohort study

Influenza vaccination coverage estimates in the fee-for service Medicare beneficiary population 2006 - 2016: Using population-based administrative data to support a geographic based near real-time tool

Effectiveness of monovalent COVID-19 booster/additional vaccine doses in the United States

Patterns of seasonal influenza activity in U.S. core-based statistical areas, described using prescriptions of oseltamivir in Medicare claims data

Relative Effectiveness of Cell-Cultured and Egg-Based Influenza Vaccines Among Elderly Persons in the United States, 2017–2018

Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018–2019

Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation

Comparative Effectiveness of Influenza Vaccines Among US Medicare Beneficiaries Ages 65 Years and Older During the 2019-2020 Season

Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation

Natural History of Coronavirus Disease 2019: Risk Factors for Hospitalizations and Deaths Among >26 Million US Medicare Beneficiaries

Recombinant Zoster Vaccine (Shingrix): Real-World Effectiveness in the First 2 Years Post-Licensure

The Reply

Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation

Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products

Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older

Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012–2013 and 2013–2014

Severe Hypoglycemia Risk With Long-Acting Insulin Analogs vs Neutral Protamine Hagedorn Insulin

Uptake and Competition Among Biosimilar Biological Products in the US Medicare Fee-for-Service Population

Risk of Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in Medicare Beneficiaries

Mortality Among Parkinson’s Disease Patients Treated With Pimavanserin or Atypical Antipsychotics: An Observational Study in Medicare Beneficiaries

Association of Pneumococcal Conjugate Vaccine Use With Hospitalized Pneumonia in Medicare Beneficiaries 65 Years or Older With and Without Medical Conditions, 2014 to 2017

Effect of Age on Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries Aged ≥65 Years

Uptake of the Biologic Filgrastim and Its Biosimilar Product Among the Medicare Population

Uptake and Usage Patterns of Biosimilar Infliximab in the Medicare Population

Severe Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent Patients

Suchergebnisse filtern